Adaptopath Liquid
NDC Package 64578-0095-1
Package Information
Adaptopath (adenosinum cyclophosphoricum, alpha-lipoicum acidum, argentum metallicum, avena sativa, capsicum annuum, citricum acidum, coenzyme a, cuprum metallicum, ginkgo biloba, glandula suprarenalis suis, glycyrrhiza glabra, hypothalamus (bovine), iodium, ledum palustre, manganum aceticum, nadidum, natrum carbonicum, oleum morrhuae, phosphoricum acidum, picricum acidum, riboflavinum, selenium metallicum sepia, silicea, thiaminum hydrochloricum, thyroidinum (bovine), vanadium metallicum) liquids is classified as a
- acidifying activity - [moa] (mechanism of action)
- allergens - [cs]
- anti-coagulant - [epc] (established pharmacologic class)
- calcium chelating activity - [moa] (mechanism of action)
- calculi dissolution agent - [epc] (established pharmacologic class)
- cell-mediated immunity - [pe] (physiologic effect)
- copper - [cs]
- copper-containing intrauterine device - [epc] (established pharmacologic class)
- decreased coagulation factor activity - [pe] (physiologic effect)
- decreased embryonic implantation - [pe] (physiologic effect)
- decreased sperm motility - [pe] (physiologic effect)
- dietary proteins - [cs]
- increased histamine release - [pe] (physiologic effect)
- inhibit ovum fertilization - [pe] (physiologic effect)
- magnetic resonance contrast activity - [moa] (mechanism of action)
- non-standardized food allergenic extract - [epc] (established pharmacologic class)
- non-standardized plant allergenic extract - [epc] (established pharmacologic class)
- paramagnetic contrast agent - [epc] (established pharmacologic class)
- plant proteins - [cs]
- vegetable proteins - [cs]
Identification & Billing
Clinical Specifications
- .ALPHA.-LIPOIC ACID 12 [hp_X]/mL
- ADENOSINE CYCLIC PHOSPHATE 8 [hp_X]/mL
- ANHYDROUS CITRIC ACID 4 [hp_X]/mL
- AVENA SATIVA FLOWERING TOP 4 [hp_X]/mL
- BOS TAURUS HYPOTHALAMUS 12 [hp_X]/mL
- CAPSICUM 4 [hp_X]/mL
- COD LIVER OIL 6 [hp_X]/mL
- COENZYME A 8 [hp_X]/mL
- COPPER 12 [hp_X]/mL
- GINKGO 4 [hp_X]/mL
- GLYCYRRHIZA GLABRA 4 [hp_X]/mL
- IODINE 12 [hp_X]/mL
- LEDUM PALUSTRE TWIG 6 [hp_X]/mL
- MANGANESE ACETATE TETRAHYDRATE 12 [hp_X]/mL
- NADIDE 12 [hp_X]/mL
- PHOSPHORIC ACID 12 [hp_X]/mL
- PICRIC ACID 12 [hp_X]/mL
- RIBOFLAVIN 12 [hp_X]/mL
- SELENIUM 12 [hp_X]/mL
- SEPIA OFFICINALIS JUICE 12 [hp_X]/mL
- SILICON DIOXIDE 12 [hp_X]/mL
- SILVER 12 [hp_X]/mL
- SODIUM CARBONATE 12 [hp_X]/mL
- SUS SCROFA ADRENAL GLAND 9 [hp_X]/mL
- THIAMINE HYDROCHLORIDE 8 [hp_X]/mL
- THYROID, BOVINE 9 [hp_X]/mL
- VANADIUM 12 [hp_X]/mL
- Acidifying Activity - [MoA] (Mechanism of Action)
- Allergens - [CS]
- Anti-coagulant - [EPC] (Established Pharmacologic Class)
- Calcium Chelating Activity - [MoA] (Mechanism of Action)
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Copper - [CS]
- Copper-containing Intrauterine Device - [EPC] (Established Pharmacologic Class)
- Decreased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Decreased Embryonic Implantation - [PE] (Physiologic Effect)
- Decreased Sperm Motility - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Inhibit Ovum Fertilization - [PE] (Physiologic Effect)
- Magnetic Resonance Contrast Activity - [MoA] (Mechanism of Action)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Paramagnetic Contrast Agent - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Vegetable Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 64578 - Energetix Corporation
- 64578-0095 - Adaptopath
- 64578-0095-1 - 59.1 mL in 1 BOTTLE, DROPPER
- 64578-0095 - Adaptopath
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 64578-0095-1 identifies a specific commercial package of 59.1 ml in 1 bottle, dropper of Adaptopath, a human over the counter drug labeled by Energetix Corporation. This liquid is formulated for oral use and contains .alpha.-lipoic acid; adenosine cyclic phosphate; anhydrous citric acid; avena sativa flowering top; bos taurus hypothalamus; capsicum; cod liver oil; coenzyme a; copper; ginkgo; glycyrrhiza glabra; iodine; ledum palustre twig; manganese acetate tetrahydrate; nadide; phosphoric acid; picric acid; riboflavin; selenium; sepia officinalis juice; silicon dioxide; silver; sodium carbonate; sus scrofa adrenal gland; thiamine hydrochloride; thyroid, bovine; vanadium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Energetix Corporation on October 22, 2014. The current certification is valid through December 31, 2026.
How is this Energetix Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 64578009501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.